BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 12181672)

  • 1. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
    Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
    Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus.
    Crawford PC; Papadi GP; Levy JK; Benson NA; Mergia A; Johnson CM
    J Infect Dis; 2001 Sep; 184(6):671-81. PubMed ID: 11517427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.
    Sparger EE; Beebe AM; Dua N; Himathongkam S; Elder JH; Torten M; Higgins J
    Virology; 1994 Dec; 205(2):546-53. PubMed ID: 7975256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein.
    Song W; Collisson EW; Li J; Wolf AM; Elder JH; Grant CK; Brown WC
    Virology; 1995 Jun; 209(2):390-9. PubMed ID: 7778274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline CD8+ cells induced with FIV infected, irradiated T cells produce multiple anti-FIV factors.
    Li Z; Phadke A; Weaver EA; Ball JM; Collisson EW
    Dev Comp Immunol; 2005; 29(9):809-24. PubMed ID: 15936436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of CD4+ and CD8+ IFN-gamma producing cells by ELISPOT in naïve and FIV-infected cats.
    Sirriyah J; Dean GA; LaVoy A; Burkhard MJ
    Vet Immunol Immunopathol; 2004 Nov; 102(1-2):77-84. PubMed ID: 15451617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
    Dean GA; LaVoy A; Burkhard MJ
    Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats.
    Gebhard DH; Dow JL; Childers TA; Alvelo JI; Tompkins MB; Tompkins WA
    J Infect Dis; 1999 Nov; 180(5):1503-13. PubMed ID: 10515809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies.
    Bull ME; Vahlenkamp TW; Dow JL; Collisson EW; Winslow BJ; Phadke AP; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 2004 May; 99(1-2):25-37. PubMed ID: 15113651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of expression patterns of feline CD28 and CTLA-4 in feline immunodeficiency virus (FIV)-infected and FIV antigen-induced PBMC.
    Choi IS; Yoo HS; Collisson EW
    J Vet Sci; 2000 Dec; 1(2):97-103. PubMed ID: 14614304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of CD8+ T cell anti-feline immunodeficiency virus (FIV) activity and FIV proviral DNA load in mononuclear cells in FIV-infected cats.
    Hohdatsu T; Nakanishi T; Saito I; Koyama H
    J Vet Med Sci; 2005 Jan; 67(1):129-31. PubMed ID: 15699611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous glucocorticoids alter parameters of early feline immunodeficiency virus infection.
    Barr MC; Huitron-Resendiz S; Selway DR; Henriksen SJ; Phillips TR
    J Infect Dis; 2000 Feb; 181(2):576-86. PubMed ID: 10669341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inducer cells in mediating in vitro suppression of feline immunodeficiency virus replication.
    Phadke AP; Choi IS; Li Z; Weaver E; Collisson EW
    Virology; 2004 Mar; 320(1):63-74. PubMed ID: 15003863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity.
    Hohdatsu T; Miyagawa N; Ohkubo M; Kida K; Koyama H
    Arch Virol; 2000; 145(12):2525-38. PubMed ID: 11205103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders.
    Paillot R; Richard S; Bloas F; Piras F; Poulet H; Brunet S; Andreoni C; Juillard V
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):1-14. PubMed ID: 15910988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
    Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
    Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG from acutely infected cats blocks mucosal feline immunodeficiency virus infection.
    Burkhard MJ; Hoover EA
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):87-95. PubMed ID: 15910995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication.
    Choi IS; Hokanson R; Collisson EW
    J Virol; 2000 Jan; 74(2):676-83. PubMed ID: 10623729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cofactor effect of feline syncytium-forming virus on feline immunodeficiency virus infection.
    Zenger E; Brown WC; Song W; Wolf AM; Pedersen NC; Longnecker M; Li J; Collisson EW
    Am J Vet Res; 1993 May; 54(5):713-8. PubMed ID: 8391229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ thymic lymphocytes express reduced levels of CD8beta and increased interferon gamma in cats perinatally infected with the JSY3 molecular clone of feline immunodeficiency virus.
    Orandle MS; Crawford PC; Levy JK; Udoji R; Papadi GP; Ciccarone T; Mergia A; Johnson CM
    AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1559-71. PubMed ID: 11054269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.